Parameter | Group | 2-way ANOVA p value | |||||
---|---|---|---|---|---|---|---|
+/+ Veh | +/+ LIRA | fa/fa Veh | fa/fa LIRA | Genotype | Treatment | Interaction | |
BW (g) | 322.1 ± 5.3 | 324.3 ± 5.8 | 518.0 ± 7.6 | 530.4 ± 14.8 | < 0.0001 | 0.475 | 0.581 |
BG (mg/dL) | 11.7 ± 0.3 | 11.1 ± 0.3 | 13.3 ± 0.9 | 10.7 ± 0.6 | 0.211 | 0.023 | 0.148 |
SBP (mmHg) | 125.9 ± 8.5 | 122.0 ± 2.9 | 132.6 ± 7.3 | 123.5 ± 3.2 | 0.018 | 0.366 | 0.182 |
HW (mg) | 764.5 ± 22.9 | 755.1 ± 12.0 | 922.4 ± 49.2 | 898.2 ± 17.3 | 0.0001 | 0.473 | 0.945 |
HW/BW ratio | 2.37 ± 0.05 | 2.33 ± 0.07 | 1.78 ± 0.09 | 1.69 ± 0.01 | < 0.0001 | 0.317 | 0.897 |
GFR (mL/min) | 1.57 ± 0.08 | 1.52 ± 0.05 | 0.98 ± 0.19 | 1.28 ± 0.05 | 0.018 | < 0.0001 | < 0.0001 |
Albumin (mg/L) | 10.0 ± 1.2 | 10.1 ± 1.2 | 75.4 ± 11.6 | 67.1 ± 14.1 | < 0.0001 | 0.665 | 0.653 |
Creatinine (mg/L) | 60.0 ± 6.5 | 76.8 ± 4.0 | 25.3 ± 4.1 | 22.2 ± 3.2 | < 0.0001 | 0.106 | 0.069 |
A/C ratio (mg/g) | 17.7 ± 3.2 | 13.3 ± 1.8 | 327.0 ± 71.1 | 285.9 ± 46.1 | < 0.0001 | 0.433 | 0.499 |
BUN (mg/dL) | 13.9 ± 1.1 | 13.9 ± 0.6 | 16.7 ± 0.6 | 14.2 ± 0.5 | 0.061 | 0.032 | 0.110 |
Serum albumin (g/dL) | 2.85 ± 0.1 | 2.86 ± 0.1 | 3.62 ± 0.2 | 3.64 ± 0.05 | < 0.0001 | 0.189 | 0.033 |